iBio, Inc. Common Stock (IBIO)

Price$2.11

Favorite Metrics

Price vs S&P 500 (26W)138.42%

Price vs S&P 500 (4W)-9.93%

Market Capitalization$72.54M

All Metrics

Book Value / Share (Quarterly)$1.88

P/TBV (Annual)1.02x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-40.30%

Cash Flow / Share (Quarterly)$-0.64

Price vs S&P 500 (YTD)6.17%

Gross Margin (TTM)52.10%

Net Profit Margin (TTM)-3049.40%

EPS (TTM)$-1.26

10-Day Avg Trading Volume0.55M

EPS Excl Extra (TTM)$-1.26

Revenue Growth (5Y)-24.59%

EPS (Annual)$-1.75

ROI (Annual)-221.12%

Gross Margin (Annual)38.40%

Net Profit Margin (5Y Avg)-4064.26%

Cash / Share (Quarterly)$1.75

ROA (Last FY)-157.79%

Revenue Growth TTM (YoY)-20.00%

EBITD / Share (TTM)$-0.92

ROE (5Y Avg)-251.07%

Operating Margin (TTM)-3113.60%

Cash Flow / Share (Annual)$-36.87

P/B Ratio1.28x

P/B Ratio (Quarterly)0.77x

Net Income / Employee (Annual)$-1

EV / Revenue (TTM)87.74x

Net Interest Coverage (TTM)-9.05x

ROA (TTM)-57.92%

EPS Incl Extra (Annual)$-1.75

Current Ratio (Annual)1.22x

Quick Ratio (Quarterly)8.93x

3-Month Avg Trading Volume4.26M

52-Week Price Return77.97%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.74

P/S Ratio (Annual)181.35x

Asset Turnover (Annual)0.02x

52-Week High$3.82

Operating Margin (5Y Avg)-3157.90%

EPS Excl Extra (Annual)$-1.75

CapEx CAGR (5Y)-57.47%

Tangible BV CAGR (5Y)-7.29%

26-Week Price Return142.41%

Quick Ratio (Annual)1.19x

13-Week Price Return-22.22%

Total Debt / Equity (Annual)0.91x

Current Ratio (Quarterly)9.04x

Enterprise Value$43.87

Revenue / Share Growth (5Y)-68.67%

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-50.39%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)3.65x

Pretax Margin (Annual)-4594.25%

Cash / Share (Annual)$4.30

3-Month Return Std Dev91.76%

Gross Margin (5Y Avg)50.77%

Net Income / Employee (TTM)$-1

ROE (Last FY)-422.14%

Net Interest Coverage (Annual)-291.78x

EPS Basic Excl Extra (Annual)$-1.75

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.26

Receivables Turnover (Annual)0.00x

ROI (TTM)-69.69%

P/S Ratio (TTM)145.08x

Pretax Margin (5Y Avg)-3001.85%

Revenue / Share (Annual)$0.04

Tangible BV / Share (Annual)$10.00

Price vs S&P 500 (52W)48.14%

Year-to-Date Return8.81%

5-Day Price Return-4.55%

EPS Normalized (Annual)$-1.75

ROA (5Y Avg)-59.82%

Net Profit Margin (Annual)-4594.25%

Month-to-Date Return10.53%

Cash Flow / Share (TTM)$-1.62

EBITD / Share (Annual)$-1.70

Operating Margin (Annual)-4650.50%

LT Debt / Equity (Annual)0.01x

ROI (5Y Avg)-75.76%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.26

P/TBV (Quarterly)0.83x

P/B Ratio (Annual)0.67x

Inventory Turnover (TTM)1.98x

Pretax Margin (TTM)-3049.40%

Book Value / Share (Annual)$15.40

Price vs S&P 500 (13W)-22.91%

Beta1.43x

Revenue / Share (TTM)$0.01

ROE (TTM)-71.26%

52-Week Low$0.56

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.30

4.27

4.25

Industry Peers — Pharmaceuticals(308)

Symbol	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
IBIOiBio, Inc. Common Stock	145.08x	-20.00%	52.10%	—	$2.11
LLYEli Lilly & Co.	13.08x	44.70%	83.04%	27.59%	$903.99
JNJJohnson & Johnson	5.94x	7.87%	67.95%	14.90%	$234.54
ABBVABBVIE INC.	6.04x	8.57%	71.62%	-2.88%	$208.99
MRKMerck & Co., Inc.	4.41x	1.31%	78.55%	21.23%	$115.46
AZNAstraZeneca PLC	5.28x	8.63%	81.31%	21.88%	$200.47
NVSNovartis AG	4.98x	8.91%	75.82%	15.26%	$149.73
NVONovo-Nordisk A/S	3.62x	6.43%	80.98%	20.66%	$40.93
ABTAbbott Laboratories	3.66x	6.59%	56.50%	8.20%	$95.47
PFEPfizer Inc.	2.47x	-1.64%	75.81%	-3.51%	$27.22
BMYBristol-Myers Squibb Co.	2.47x	-0.22%	72.63%	—	$58.96

About

iBio Inc is a preclinical-stage biotechnology company that uses artificial intelligence to develop precision antibodies and provide contract manufacturing services. The company's AI-driven platform employs epitope-steering and monoclonal antibody optimization to reduce development risk and accelerate time to clinic.